Free weekly newsletter
Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
Weekly Digest
New new contracts, summarized for you
Straight to Inbox
No login, no app to check — it comes to you
Contract Trends
See who's moving and how much in your market
No credit card required Weekly contract digest
HAYA Therapeutics Partners with Lilly Gateway Labs to Enhance RNA-Guided Therapeutics Development
Jun 03, 2025•about 1 year ago
Contract Type
partnership
Description
HAYA Therapeutics has relocated its U.S. operations to Lilly Gateway Labs in San Diego to leverage world-class facilities and a dynamic scientific environment. This move will support the advancement of their RNA-guided therapeutics platform and clinical development efforts for heart failure treatments.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months